Description: Dong Sung Bio Pharm.Co.,Ltd. engages in the pharmaceuticals, cosmetics, hair dye, and photodynamic therapy businesses in South Korea. It offers OTC drugs, such as liver disease treatment, climacterium, skin disease, obesity, digestive, gingival, alopecia, antipyretic, analgesic, anti-inflammatory, respiratory, scar-recovery, sleep inducer, antidiarrhotica, antiemetic, antiviral, blood circulation enhancer, antifungal, and anti-histamine drugs, as well as keratin softeners, optic nutrition supplements, and vitamins. The company also provides ETC drugs, including endocrine, gastrointestinal, circulatory, neuropsychologic, tumor, analgesic/anti-inflammation, dermato-urinary, anti-viral, antibiotic, antifungal, anti-histamine, and respiratory drugs, as well as steroids and eye drops. In addition, it offers hair dyeing agents, health functional foods, medical devices, daily supplies, muscle taping products, disinfectants, toothpastes, anti-hair loss and hair increase shampoos, sanitary pads, and other products. The company was founded in 1957 and is headquartered in Seoul, South Korea.
Home Page: dongsung-pharm.com
Dongsung Building
Seoul,
01340
South Korea
Phone:
82 2 6911 3600
Officers
| Name | Title |
|---|---|
| Mr. Yang-Gu Lee | Chief Exec. Officer |
| Eun-Shin Lee | Director of Sales Management Department and Director |
| Mr. Man-Sik Bae | Managing Director |
| Mr. In-Kyu Kim | Sr. Managing Director |
| Sang-Yi Nam | Managing Director |
| Kyu-Yong Lim | Director of Sales Department and Director |
| Chul-Ho Kim | Director of H&B Bus. Department and Director |
| Ho-Won Jung | Director of Management Department and Director |
| Bong-Lim Cho | Director of Sanitary Aids Research Center and Director |
| Se-Soon Hwang | Director of Sales Department and Director |
Exchange: KO
Country: KR : Korea (Republic of)
Currency: Korean Won (₩)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.7222 |
| Price-to-Sales TTM: | 2.0055 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 298 |